
About Cravatex
Cravatex is a publicly listed company based in Mumbai (India) founded in 1951. International brands are franchised, licensed, and distributed globally by Cravatex. The company has 8 employees. Its Indian entity Cravatex Limited reported revenue of βΉ168 Cr. Its focus areas include Consumer Goods, Retail Chains, Sporting & Outdoor Goods and Multi-Category.
Company details
Cravatex was founded in 1951 and operates as a retail, brand licensing, distribution, and sourcing company. Presence is maintained across the Indian Subcontinent, United Kingdom, Europe, North Africa, and the Middle East. Licenses for brands such as Fila are held in India and select other regions, supporting retail and distribution activities in the apparel and consumer goods sector.
- Headquarters Mumbai, India
- Employees 8
- Stage Public
- SectorsRetail
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website cravatex.com
- Social LinkedIn
- Legal Name Cravatex Limited
- Market Cap₹84.16 Cr
CRAVATEX · NSE
- Share Price₹337.50
+3.46% today
- Revenue₹151 Cr
FY 2025-26 · -13.2% YoY
- EBITDA−₹6.37 Cr
Margin -4.2%
- Net Profit₹6.72 Cr
FY 2025-26 · +40.0% YoY
- P/E (TTM)11.1x
P/B 0.7x
- ROE6.0%
ROCE 7.7%
- Latest Funding Round$11.46M (USD), Post-IPO
Mar 2017
- Investors
- Employee Count8
Associated legal entities of Cravatex
Cravatex operates through Cravatex Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cravatex Limited Listed CIN L93010MH1951PLC008546 | Active | 22 Jun 1951 | Mumbai, Maharashtra | ₹168 Cr | 6 | 9 | View details |
Funding Insights of Cravatex
- Total Rounds 1
- Last Round Post-IPO β $11.46M
- First Round $11.46M
(Mar 2017)
- Investors Count 1
All 1 funding rounds of Cravatex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2017 | $11.46M | Post-IPO | β | β |
1 investors in total: 1 institutional.
Investors in Cravatex
Cravatex has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Paragon Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A leading Indian mid-market private equity firm is operated. | 2015 | paragonpartners.in | Mumbai, India |
Investor details for Cravatex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cravatex Limited (Cravatex)
Cravatex Limited is the primary company behind Cravatex. The board of Cravatex Limited currently have 7 directors; the longest-serving is Rajesh Kumar Batra, appointed in 1981. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajesh Kumar Batra DIN 00020764 | Managing Director | 30 Nov 1981 | 44 yrs 11 mo | Cravatex Limited |
| Pheroza Jimmy Bilimoria DIN 00191386 | Director | 16 Sep 2014 | 12 yrs 2 mo | Cravatex Limited |
| Rohan Kumar Batra DIN 02574195 | Director | 01 Apr 2020 | 6 yrs 7 mo | Cravatex Limited |
| Divakar Ganapati Kamath DIN 08730430 | Director | 01 Apr 2020 | 6 yrs 7 mo | Cravatex Limited |
| Satyan Shivkumar Israni DIN 01174081 | Director | 12 Feb 2024 | 2 yrs 9 mo | Cravatex Limited |
| Nakul Toshniwal DIN 00350112 | Director | 15 Feb 2024 | 2 yrs 9 mo | Cravatex Limited |
| Rina Suresh Deora DIN 00774812 | Director | 20 May 2025 | 1 yr 5 mo | Cravatex Limited |
People of Cravatex
1 people are tracked at Cravatex (1 in leadership); the tracked headcount is 8.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership |
Complete people profiles for Cravatex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Cravatex
Cravatex is a publicly listed company on the BSE with ticker symbol CRAVATEX in India, operating in the Retail trade sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 Mar 1980
- Listed onBSE: 509472
- Listed entityCravatex Limited
- Exchange sectorRetail trade
- ISININE145E01017
- Share price₹354.00 · 2026-05-11
- Market capitalisation₹91.5 Cr
- Price to earnings13.8
- EPS (diluted, trailing year)₹25.69
- Dividend yield3.53%
- Volume (last session)378
- Analyst consensusNo rating
Financials of Cravatex
Exchange-reported figures of Cravatex Limited, the listed company behind Cravatex (NSE: CRAVATEX).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 151 | 174 | 203 | 504 | 594 | 532 | 865 |
| Revenue growth | -13.2% | -14.3% | -59.8% | -15.3% | +11.7% | -38.5% | - |
| EBITDA | (6.37) | (1.68) | (7.65) | (29.89) | 2.05 | (11.88) | 21.25 |
| EBITDA margin | -4.2% | -1.0% | -3.8% | -5.9% | +0.3% | -2.2% | +2.5% |
| Profit before tax | 8.58 | 6.38 | 6.16 | 58.34 | (18.56) | (29.75) | (2.41) |
| Net profit | 6.72 | 4.80 | 4.81 | (45.14) | (20.04) | (30.13) | (4.71) |
| Net profit margin | +4.5% | +2.8% | +2.4% | -9.0% | -3.4% | -5.7% | -0.5% |
| EPS (βΉ) | 26.30 | 18.68 | 18.68 | 228.05 | (76.95) | (118.45) | (18.24) |
| Balance sheet | |||||||
| Total assets | 122 | 110 | 102 | 94.02 | 219 | 238 | 282 |
| Net worth | 119 | 106 | 98.72 | 92.36 | 29.86 | 55.78 | 63.16 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 87.51 | 70.59 | 138 |
| Cash & bank | 76.62 | 75.45 | 76.05 | 56.32 | 37.97 | 36.07 | 49.32 |
| Net working capital | 94.33 | 84.36 | 84.58 | 78.70 | 145 | 141 | 157 |
| Cash flow | |||||||
| Cash from operations | 1.27 | 2.99 | 19.06 | 144 | (7.56) | (3.82) | 32.02 |
| Cash from investing | 3.29 | (0.64) | (1.32) | 42.42 | 13.93 | 20.55 | (37.33) |
| Cash from financing | (3.23) | (0.78) | (0.39) | (168) | (3.69) | (20.71) | 37.43 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 53.46 | 32.22 | 39.51 | 36.79 | 51.45 | 23.13 | 60.52 | 32.43 |
| Revenue growth (YoY) | +3.9% | +39.3% | -34.7% | +13.4% | -6.5% | -10.3% | - | - |
| Other income | 3.37 | 4.40 | 3.30 | 4.52 | 3.80 | 5.21 | 2.09 | 2.24 |
| EBITDA | 3.05 | (3.28) | (0.60) | (2.44) | 2.76 | (6.10) | 0.50 | (1.87) |
| EBITDA margin | +5.7% | -10.2% | -1.5% | -6.6% | +5.4% | -26.4% | +0.8% | -5.8% |
| Depreciation | 0.38 | 0.38 | 0.37 | 0.38 | 0.38 | 0.38 | 0.40 | 0.40 |
| Interest | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.11 |
| Profit before tax | 5.96 | 0.66 | 2.24 | 1.61 | 6.09 | (1.36) | 2.10 | (0.14) |
| Tax | 1.35 | 0.23 | 0.64 | 0.27 | 0.87 | 0.01 | 0.67 | (0.39) |
| Net profit | 4.61 | 0.43 | 1.60 | 1.34 | 5.22 | (1.37) | 1.43 | 0.25 |
| EPS (βΉ) | 17.88 | 1.70 | 6.19 | 5.21 | 20.18 | (5.29) | 5.59 | 0.97 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 7.10 | 4.80 | 1.87 | 3.48 | 2.44 | 2.31 | 2.42 |
| Revenue growth | +47.9% | +156.7% | -46.3% | +42.6% | +5.6% | -4.6% | - |
| EBITDA | (2.33) | (2.67) | (2.28) | (35.49) | (2.23) | (2.43) | (2.90) |
| EBITDA margin | -32.8% | -55.6% | -121.9% | -1019.8% | -91.4% | -105.2% | -119.8% |
| Profit before tax | 5.74 | 5.40 | 3.36 | (27.79) | 5.09 | 6.19 | 2.55 |
| Net profit | 5.45 | 4.83 | 3.53 | 5.01 | 4.34 | 5.86 | 2.31 |
| Net profit margin | +76.8% | +100.6% | +188.8% | +144.0% | +177.9% | +253.7% | +95.5% |
| EPS (βΉ) | 21.48 | 18.82 | 13.69 | (105.03) | 16.98 | 22.31 | 8.98 |
| Balance sheet | |||||||
| Total assets | 26.06 | 24.69 | 20.74 | 15.92 | 50.14 | 48.01 | 40.69 |
| Net worth | 23.80 | 21.50 | 17.45 | 14.26 | 46.20 | 42.55 | 36.96 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Cash & bank | 0.25 | 0.38 | 3.24 | 3.43 | 0.93 | 0.57 | 0.21 |
| Net working capital | (0.67) | 0.31 | 2.86 | 0.51 | (1.78) | (0.73) | (2.09) |
| Cash flow | |||||||
| Cash from operations | (2.50) | (3.39) | (2.46) | (5.18) | (3.23) | (2.02) | (2.04) |
| Cash from investing | 5.76 | 3.46 | 0.29 | 16.05 | 5.27 | 3.63 | 5.12 |
| Cash from financing | (3.23) | (0.78) | (0.39) | (8.36) | (1.67) | (1.23) | (3.77) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.47 | 1.44 | 0.00 | 3.13 | 2.53 | 1.44 | 0.00 | 2.54 |
| Revenue growth (YoY) | -41.9% | 0.0% | - | +23.2% | +12.0% | - | - | - |
| Other income | 1.41 | 1.40 | 3.14 | 3.63 | 1.26 | 1.35 | 1.44 | 3.40 |
| Total expenses | 2.12 | 2.05 | 0.57 | 3.74 | 3.12 | 2.02 | 0.91 | 3.15 |
| EBITDA | (0.65) | (0.61) | (0.57) | (0.61) | (0.59) | (0.58) | (0.91) | (0.61) |
| EBITDA margin | -44.2% | -42.4% | - | -19.5% | -23.3% | -40.3% | - | -24.0% |
| Depreciation | 0.24 | 0.23 | 0.24 | 0.24 | 0.24 | 0.23 | 0.26 | 0.26 |
| Interest | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 | 0.09 | 0.11 |
| Profit before tax | 0.44 | 0.48 | 2.25 | 2.69 | 0.34 | 0.45 | 0.18 | 2.42 |
| Tax | (0.01) | 0.06 | 0.11 | 0.07 | 0.01 | 0.01 | 0.16 | (0.04) |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 53.46 | 32.22 | 39.51 | 36.79 | 51.45 | 23.13 | 60.52 | 32.43 |
| Revenue growth (YoY) | +3.9% | +39.3% | -34.7% | +13.4% | -6.5% | -10.3% | - | - |
| Other income | 3.37 | 4.40 | 3.30 | 4.52 | 3.80 | 5.21 | 2.09 | 2.24 |
| EBITDA | 3.05 | (3.28) | (0.60) | (2.44) | 2.76 | (6.10) | 0.50 | (1.87) |
| EBITDA margin | +5.7% | -10.2% | -1.5% | -6.6% | +5.4% | -26.4% | +0.8% | -5.8% |
| Depreciation | 0.38 | 0.38 | 0.37 | 0.38 | 0.38 | 0.38 | 0.40 | 0.40 |
| Interest | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.11 |
| Profit before tax | 5.96 | 0.66 | 2.24 | 1.61 | 6.09 | (1.36) | 2.10 | (0.14) |
| Tax | 1.35 | 0.23 | 0.64 | 0.27 | 0.87 | 0.01 | 0.67 | (0.39) |
| Net profit | 4.61 | 0.43 | 1.60 | 1.34 | 5.22 | (1.37) | 1.43 | 0.25 |
| EPS (βΉ) | 17.88 | 1.70 | 6.19 | 5.21 | 20.18 | (5.29) | 5.59 | 0.97 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 151 | 174 | 203 | 504 | 594 | 532 | 865 |
| Revenue growth | -13.2% | -14.3% | -59.8% | -15.3% | +11.7% | -38.5% | - |
| Other income | 16.82 | 9.95 | 16.10 | 118 | 9.93 | 14.31 | 5.26 |
| Total expenses | 157 | 175 | 210 | 534 | 592 | 544 | 843 |
| Employee cost | 32.44 | 27.08 | 28.93 | 60.72 | 64.72 | 64.16 | 70.99 |
| EBITDA | (6.37) | (1.68) | (7.65) | (29.89) | 2.05 | (11.88) | 21.25 |
| EBITDA margin | -4.2% | -1.0% | -3.8% | -5.9% | +0.3% | -2.2% | +2.5% |
| Depreciation | 1.51 | 1.48 | 1.88 | 16.14 | 16.37 | 17.44 | 14.98 |
| Interest | 0.36 | 0.41 | 0.41 | 13.81 | 14.17 | 14.74 | 13.94 |
| Profit before tax | 8.58 | 6.38 | 6.16 | 58.34 | (18.56) | (29.75) | (2.41) |
| Tax | 1.78 | 1.55 | 1.33 | (0.60) | 1.34 | 0.85 | 2.29 |
| Net profit | 6.72 | 4.80 | 4.81 | (45.14) | (20.04) | (30.13) | (4.71) |
| Net profit margin | +4.5% | +2.8% | +2.4% | -9.0% | -3.4% | -5.7% | -0.5% |
| EPS (βΉ) | 26.30 | 18.68 | 18.68 | 228.05 | (76.95) | (118.45) | (18.24) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 2.58 | 2.58 | 2.58 | 2.58 | 82.21 | 86.65 | 66.77 |
| Reserves & surplus | 117 | 104 | 96.14 | 89.78 | (52.35) | (30.87) | (3.61) |
| Shareholders' funds (net worth) | 119 | 106 | 98.72 | 92.36 | 29.86 | 55.78 | 63.16 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 75.24 | 75.24 | 71.09 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 72.51 | 70.59 | 77.42 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 15.00 | 0.00 | 60.31 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 87.51 | 70.59 | 138 |
| Total liabilities | 122 | 110 | 102 | 94.02 | 219 | 238 | 282 |
| Assets | |||||||
| Gross block | 22.56 | 22.53 | 22.94 | 21.94 | 103 | 110 | 123 |
| Net block | 8.34 | 8.99 | 8.78 | 8.09 | 61.53 | 76.46 | 92.14 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 18.72 | 15.89 | 8.09 | 4.62 | 4.60 | 14.79 | 24.56 |
| Inventories | 23.01 | 11.48 | 10.67 | 29.04 | 94.34 | 85.00 | 81.61 |
| Sundry debtors | 16.33 | 23.96 | 13.85 | 26.21 | 133 | 143 | 169 |
| Cash & bank balances | 76.62 | 75.45 | 76.05 | 56.32 | 37.97 | 36.07 | 49.32 |
| Loans & advances | 2.82 | 4.56 | 6.53 | 9.77 | 24.51 | 23.04 | 15.85 |
| Total current assets | 119 | 115 | 107 | 121 | 290 | 287 | 316 |
| Total current liabilities | 24.45 | 31.09 | 22.52 | 42.64 | 145 | 146 | 159 |
| Net working capital | 94.33 | 84.36 | 84.58 | 78.70 | 145 | 141 | 157 |
| Total assets | 122 | 110 | 102 | 94.02 | 219 | 238 | 282 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 75.21 | 73.64 | 56.29 | 37.92 | 35.25 | 39.23 | 7.11 |
| Net cash from operating activities | 1.27 | 2.99 | 19.06 | 144 | (7.56) | (3.82) | 32.02 |
| Net cash from investing activities | 3.29 | (0.64) | (1.32) | 42.42 | 13.93 | 20.55 | (37.33) |
| Net cash from financing activities | (3.23) | (0.78) | (0.39) | (168) | (3.69) | (20.71) | 37.43 |
| Net change in cash | 1.33 | 1.57 | 17.35 | 18.36 | 2.68 | (3.98) | 32.12 |
| Closing cash | 76.62 | 75.45 | 76.05 | 56.32 | 37.97 | 36.07 | 49.32 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -13.2% | -14.3% | -59.8% | -15.3% | +11.7% | -38.5% | - |
| EBITDA growth | -279.2% | +78.0% | +74.4% | -1558.1% | +117.3% | -155.9% | - |
| PBT growth | +34.5% | +3.6% | -89.4% | +9998.0% | +37.6% | -1134.4% | - |
| Net income growth | +40.0% | -0.2% | +110.7% | -125.3% | +33.5% | -539.7% | - |
| Revenue CAGR (3Y) | -33.1% | -33.6% | -27.5% | -16.5% | -6.1% | +14.3% | +48.1% |
| EBITDA CAGR (3Y) | -40.3% | - | -13.7% | - | -56.0% | +28.4% | - |
| Profitability & leverage | |||||||
| Net income margin | +4.5% | +2.8% | +2.4% | +11.7% | -3.4% | -5.8% | -0.5% |
| Return on capital employed | +7.7% | +6.4% | +6.7% | -28.9% | 0.0% | 0.0% | +6.5% |
| Return on net worth | +6.0% | +4.7% | +5.1% | -212.0% | 0.0% | 0.0% | -50.3% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.72 | 1.85 | 1.75 | 1.28 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.22 | 0.31 | 0.45 | 0.49 |
| Interest cover | -4.57 | -12.97 | -4.30 | -30.00 | -98.95 | -50.27 | 222.33 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 6.69 | 7.64 | 9.03 | 8.03 | 5.57 | 4.56 | 9.16 |
| Inventory turnover | 8.75 | 15.69 | 10.21 | 8.16 | 6.63 | 6.38 | 10.46 |
| Debtors turnover | 7.49 | 9.19 | 10.12 | 6.32 | 4.30 | 3.40 | 5.41 |
| EPS (βΉ) | 26.30 | 18.68 | 18.68 | 228.05 | (76.95) | (118.45) | (18.24) |
| Dividend per share (βΉ) | 13.00 | 12.50 | 3.00 | 1.50 | 3.00 | 3.00 | 3.00 |
| Book value per share (βΉ) | 462.18 | 411.83 | 382.02 | 357.42 | (192.58) | (109.44) | (3.96) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.47 | 1.44 | 0.00 | 3.13 | 2.53 | 1.44 | 0.00 | 2.54 |
| Revenue growth (YoY) | -41.9% | 0.0% | - | +23.2% | +12.0% | - | - | - |
| Other income | 1.41 | 1.40 | 3.14 | 3.63 | 1.26 | 1.35 | 1.44 | 3.40 |
| Total expenses | 2.12 | 2.05 | 0.57 | 3.74 | 3.12 | 2.02 | 0.91 | 3.15 |
| EBITDA | (0.65) | (0.61) | (0.57) | (0.61) | (0.59) | (0.58) | (0.91) | (0.61) |
| EBITDA margin | -44.2% | -42.4% | - | -19.5% | -23.3% | -40.3% | - | -24.0% |
| Depreciation | 0.24 | 0.23 | 0.24 | 0.24 | 0.24 | 0.23 | 0.26 | 0.26 |
| Interest | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 | 0.09 | 0.11 |
| Profit before tax | 0.44 | 0.48 | 2.25 | 2.69 | 0.34 | 0.45 | 0.18 | 2.42 |
| Tax | (0.01) | 0.06 | 0.11 | 0.07 | 0.01 | 0.01 | 0.16 | (0.04) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 7.10 | 4.80 | 1.87 | 3.48 | 2.44 | 2.31 | 2.42 |
| Revenue growth | +47.9% | +156.7% | -46.3% | +42.6% | +5.6% | -4.6% | - |
| Other income | 9.38 | 9.53 | 7.39 | 9.89 | 8.76 | 10.02 | 7.11 |
| Total expenses | 9.43 | 7.47 | 4.15 | 38.97 | 4.67 | 4.74 | 5.32 |
| Employee cost | 1.57 | 1.48 | 1.30 | 1.47 | 1.22 | 0.94 | 1.15 |
| EBITDA | (2.33) | (2.67) | (2.28) | (35.49) | (2.23) | (2.43) | (2.90) |
| EBITDA margin | -32.8% | -55.6% | -121.9% | -1019.8% | -91.4% | -105.2% | -119.8% |
| Depreciation | 0.95 | 1.05 | 1.34 | 0.81 | 0.70 | 0.74 | 0.85 |
| Interest | 0.36 | 0.41 | 0.41 | 1.38 | 0.74 | 0.66 | 0.81 |
| Profit before tax | 5.74 | 5.40 | 3.36 | (27.79) | 5.09 | 6.19 | 2.55 |
| Tax | 0.19 | 0.53 | (0.19) | (0.64) | 0.71 | 0.42 | 0.24 |
| Net profit | 5.45 | 4.83 | 3.53 | 5.01 | 4.34 | 5.86 | 2.31 |
| Net profit margin | +76.8% | +100.6% | +188.8% | +144.0% | +177.9% | +253.7% | +95.5% |
| EPS (βΉ) | 21.48 | 18.82 | 13.69 | (105.03) | 16.98 | 22.31 | 8.98 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 2.58 | 2.58 | 2.58 | 2.58 | 6.61 | 6.57 | 6.47 |
| Reserves & surplus | 21.22 | 18.92 | 14.87 | 11.68 | 39.59 | 35.98 | 30.49 |
| Shareholders' funds (net worth) | 23.80 | 21.50 | 17.45 | 14.26 | 46.20 | 42.55 | 36.96 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Total liabilities | 26.06 | 24.69 | 20.74 | 15.92 | 50.14 | 48.01 | 40.69 |
| Assets | |||||||
| Gross block | 12.03 | 12.19 | 14.66 | 13.50 | 14.25 | 14.49 | 16.21 |
| Net block | 6.81 | 7.30 | 8.42 | 7.39 | 7.73 | 8.42 | 8.32 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 19.14 | 16.31 | 8.51 | 5.04 | 43.13 | 40.35 | 35.10 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Sundry debtors | 0.00 | 0.01 | 0.02 | 0.12 | 0.01 | 0.15 | 0.63 |
| Cash & bank balances | 0.25 | 0.38 | 3.24 | 3.43 | 0.93 | 0.57 | 0.21 |
| Loans & advances | 0.94 | 1.35 | 1.27 | 0.87 | 0.62 | 0.87 | 0.92 |
| Total current assets | 1.19 | 1.74 | 4.53 | 4.42 | 1.56 | 1.60 | 1.77 |
| Total current liabilities | 1.86 | 1.43 | 1.67 | 3.91 | 3.34 | 2.33 | 3.86 |
| Net working capital | (0.67) | 0.31 | 2.86 | 0.51 | (1.78) | (0.73) | (2.09) |
| Total assets | 26.06 | 24.69 | 20.74 | 15.92 | 50.14 | 48.01 | 40.69 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.14 | 0.84 | 3.39 | 0.89 | 0.52 | 0.14 | 0.83 |
| Net cash from operating activities | (2.50) | (3.39) | (2.46) | (5.18) | (3.23) | (2.02) | (2.04) |
| Net cash from investing activities | 5.76 | 3.46 | 0.29 | 16.05 | 5.27 | 3.63 | 5.12 |
| Net cash from financing activities | (3.23) | (0.78) | (0.39) | (8.36) | (1.67) | (1.23) | (3.77) |
| Net change in cash | 0.03 | (0.70) | (2.56) | 2.51 | 0.37 | 0.38 | (0.70) |
| Closing cash | 0.25 | 0.38 | 3.24 | 3.43 | 0.93 | 0.57 | 0.21 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +47.9% | +156.7% | -46.3% | +42.6% | +5.6% | -4.6% | - |
| EBITDA growth | +12.7% | -17.1% | +93.6% | -1491.5% | +8.2% | +16.2% | - |
| PBT growth | +6.3% | +60.7% | +9998.0% | - | -17.8% | +142.8% | -13.6% |
| Net income growth | +12.8% | +36.8% | -29.5% | +15.4% | -25.9% | +153.7% | - |
| Revenue CAGR (3Y) | +26.8% | +25.3% | -6.8% | +12.9% | +32.9% | +46.2% | -75.1% |
| EBITDA CAGR (3Y) | -59.7% | +6.2% | -2.1% | +130.5% | -0.3% | -3.2% | +12.8% |
| Profitability & leverage | |||||||
| Net income margin | +78.2% | +101.5% | +189.8% | -780.2% | +179.5% | +249.8% | +95.5% |
| Return on capital employed | +24.0% | +25.5% | +20.6% | 0.0% | +11.9% | +15.5% | +8.2% |
| Return on net worth | +24.5% | +25.0% | +22.3% | 0.0% | +10.9% | +16.1% | +7.2% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | -10.98 | -11.02 | -11.33 | -3.80 | -25.26 | -20.82 | -21.60 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.59 | 0.36 | 0.13 | 0.25 | 0.17 | 0.15 | 0.15 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 488.00 | 231.00 | 96.80 |
| Debtors turnover | 1,420.00 | 320.00 | 26.71 | 53.54 | 30.50 | 5.92 | 5.63 |
| EPS (βΉ) | 21.48 | 18.82 | 13.69 | (105.03) | 16.98 | 22.31 | 8.98 |
| Dividend per share (βΉ) | 13.00 | 12.50 | 3.00 | 1.50 | 3.00 | 3.00 | 3.00 |
| Book value per share (βΉ) | 92.12 | 83.21 | 67.53 | 55.20 | 163.18 | 149.23 | 127.99 |
Timeline of Cravatex
3 dated milestones of Cravatex across 66 years, from founding to its latest funding, stage changes and deals.
- Founded Cravatex is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $11.5M.
Web traffic of Cravatex
The website of Cravatex (cravatex.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 2.8% vs previous month
Top companies in Retail Stores & Chains
2 companies that operate in the same segment as Cravatex (Retail Stores & Chains) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Online platform offering a wide range of baby, kids, and maternity products | 2010 | Pune, Maharashtra, India | USD 513.39 M | USD 911.07 M | 3,752 | |
Multi-format offline retail is operated in India. | 1997 | Mumbai, Maharashtra, India | USD 3.41 B | USD 280.87 K | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cravatex
Complete news archive for Cravatex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cravatex
Cravatex was founded in 1951 and raised its 1st funding round 66 years after it was founded.
Cravatex is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Cravatex has 8 employees.
The primary company behind Cravatex, Cravatex Limited, reported revenue of βΉ168 Cr for FY 2026, down 13% year on year.
Cravatex was founded in 1951 and operates as a retail, brand licensing, distribution, and sourcing company. Presence is maintained across the Indian Subcontinent, United Kingdom, Europe, North Africa, and the Middle East. Licenses for brands such as Fila are held in India and select other regions, supporting retail and distribution activities in the apparel and consumer goods sector.
Yes, Cravatex is publicly traded on BSE under the ticker symbol CRAVATEX.
Cravatex has 1 investor. Key investors include Paragon Partners.
Cravatex operates through Cravatex Limited.
The legal entities of Cravatex currently have 8 directors, including Rohan Kumar Batra, Divakar Ganapati Kamath, Pheroza Jimmy Bilimoria and others.
